We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$25.1B
AUM Growth
-$1.52B
(-5.7%)
Cap. Flow
-$491M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
22.13%
Holding
697
New
161
Increased
139
Reduced
161
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$563M |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
Salesforce
CRM
|
+$308M |
| 4 |
EA
Electronic Arts
EA
|
+$210M |
| 5 |
Wayfair
W
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$876M |
| 2 |
Meta Platforms (Facebook)
META
|
+$445M |
| 3 |
Alibaba
BABA
|
+$417M |
| 4 |
Boeing
BA
|
+$333M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.42% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Healthcare | 10.34% |
| 4 | Industrials | 10.11% |
| 5 | Real Estate | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TLN
401
Talen Energy Corp
TLN
$16.4B
| $2.81M | 0.01% |
14,074
-85,482
| -86% | -$18.5M |
|
402
Evolus
EOLS
$500M
| $2.71M | 0.01% |
225,000
-100,000
| -31% | -$1.31M |
|
403
Amylyx Pharmaceuticals
AMLX
$2.53B
| $2.66M | 0.01% |
750,412
-73,008
| -9% | -$260K |
|
404
AerSale
ASLE
$277M
| $2.59M | 0.01% |
346,411
-753,589
| -69% | -$5.39M |
|
405
Biohaven
BHVN
$2.19B
| $2.56M | 0.01% |
106,351
| – | – |
|
406
Eli Lilly
LLY
$1.1T
| $2.52M | 0.01% |
+3,055
| New | +$2.54M |
|
407
Toll Brothers
TOL
$14B
| $2.51M | 0.01% |
23,742
-17,367
| -42% | -$2.09M |
|
408
Oculis Holding
OCS
$709M
| $2.5M | 0.01% |
+131,332
| New | +$2.69M |
|
|
KMTS
409
Kestra Medical Technologies
KMTS
$1.66B
| $2.49M | 0.01% |
+100,000
| New | +$2.3M |
|
410
Arbe Robotics
ARBE
$89.8M
| $2.41M | 0.01% |
2,339,726
-1,760,693
| -43% | -$3.88M |
|
|
AVR
411
Anteris Technologies
AVR
$872M
| $2M | 0.01% |
550,000
| – | – |
|
412
Pentair
PNR
$10.7B
| $1.99M | 0.01% |
+22,783
| New | +$2.17M |
|
413
Denison Mines
DNN
$2.95B
| $1.95M | 0.01% |
1,500,000
-18,409,605
| -92% | -$30.7M |
|
|
SION
414
Sionna Therapeutics
SION
$203M
| $1.95M | 0.01% |
+186,222
| New | +$3.04M |
|
415
Beyond Air
XAIR
$3.75M
| $1.95M | 0.01% |
17,855
| – | – |
|
416
EyePoint Inc
EYPT
$1.13B
| $1.9M | 0.01% |
351,348
| – | – |
|
417
Endava
DAVA
$159M
| $1.89M | 0.01% |
96,709
-1,709,335
| -95% | -$47.4M |
|
418
Modular Medical
MODD
$10.8M
| $1.86M | 0.01% |
56,944
+34,722
| +156% | +$1.16M |
|
|
TRML
419
DELISTED
Tourmaline Bio
TRML
| $1.75M | 0.01% |
115,053
| – | – |
|
|
ACOG
420
Alpha Cognition
ACOG
$194M
| $1.71M | 0.01% |
337,466
-62,534
| -16% | -$365K |
|
421
KB Home
KBH
$3.47B
| $1.69M | 0.01% |
+29,135
| New | +$1.86M |
|
|
RGLS
422
DELISTED
Regulus Therapeutics
RGLS
| $1.64M | 0.01% |
937,500
-100,000
| -10% | -$132K |
|
423
Health Catalyst
HCAT
$129M
| $1.58M | 0.01% |
349,194
-1,670,186
| -83% | -$8.84M |
|
|
SLRN
424
DELISTED
ACELYRIN
SLRN
| $1.52M | 0.01% |
615,878
-900,000
| -59% | -$2.14M |
|
|
APLT
425
DELISTED
Applied Therapeutics
APLT
| $1.52M | 0.01% |
3,107,497
+400,000
| +15% | +$236K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2025 Portfolio in Review
As of Q1 2025, Alyeska Investment Group held 697 positions worth $25.1B, down 5.7% from $26.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Alyeska Investment Group's Q1 2025 filing shows 161 new, 139 increased, 161 reduced and 204 closed positions. Its largest new stake was Salesforce: 988,971 shares worth $265M. The largest sale was iShares Core S&P 500 ETF, an estimated $876M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Alyeska Investment Group's largest Q1 2025 buy was Salesforce: 988,971 shares worth $265M.
- Alyeska Investment Group added most to Amazon in Q1 2025, an estimated $563M increase.
- Alyeska Investment Group's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $876M.
- Alyeska Investment Group fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $321M.
- Alyeska Investment Group's ten largest holdings make up 22% of its $25.1B portfolio in Q1 2025.
- Alyeska Investment Group opened 161 new positions and closed 204 in Q1 2025.
- Alyeska Investment Group's portfolio value fell 5.7% quarter-over-quarter to $25.1B.
Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.